Notable
UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
Recruitment opened
Umoja BiopharmaPhase 1/2 NCT07735533 Registry history of NCT07735533 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Recruitment opened
Umoja BiopharmaPhase 1/2 NCT07735533 Registry history of NCT07735533 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 2 | |
| Phase 1/2 | 1 |
DLBCL (2) · Non-Hodgkin Lymphoma (2) · Chronic Lymphocytic Leukemia (CLL) (1) · Follicular Lymphoma (1) · Leukemia (1) · Multiple Myeloma (1)